Literature DB >> 15185386

Using stated preference and revealed preference modeling to evaluate prescribing decisions.

Tami L Mark1, Joffre Swait.   

Abstract

The use of stated preference analyses to evaluate choice of health care products has been growing in recent years. This paper shows how revealed preference data can be enriched with stated preference data and highlights the relative advantages of revealed and stated preference data. The techniques were applied to a study of determinants of physicians' prescriptions of alcoholism medications. Analyses were conducted on the relationship between physicians' perceptions of existing alcoholism medication attributes and their prescribing rates of those medications. Analyses were also conducted on physicians' decisions to prescribe hypothetical alcoholism medications with varying attributes such as efficacy, side effects, compliance, mode of action, and price. Finally, analyses were conducted on the combined stated and revealed preference data. Joint estimation suggests that parameters from the revealed and stated preference data are equal, up to scale. Joint analyses highlight how stated preference data can be used to estimate parameters for attributes that are not observed in the marketplace, that do not vary in the marketplace, or that are highly collinear with other attributes in actual markets. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15185386     DOI: 10.1002/hec.845

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  30 in total

1.  Using Historical Variation in Opioid Prescribing Immediately After Fracture Surgery to Guide Maximum Initial Prescriptions.

Authors:  Abhiram R Bhashyam; Matthew Basilico; Michael J Weaver; Mitchel B Harris; Marilyn Heng
Journal:  J Orthop Trauma       Date:  2019-04       Impact factor: 2.512

2.  A closer look at decision and analyst error by including nonlinearities in discrete choice models: implications on willingness-to-pay estimates derived from discrete choice data in healthcare.

Authors:  Esther W de Bekker-Grob; John M Rose; Michiel C J Bliemer
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

3.  Adoption and implementation of medications in addiction treatment programs.

Authors:  Hannah K Knudsen; Amanda J Abraham; Paul M Roman
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

4.  Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software.

Authors:  Emily Lancsar; Denzil G Fiebig; Arne Risa Hole
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

5.  Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys.

Authors:  F Reed Johnson; Semra Ozdemir; Kathryn A Phillips
Journal:  Soc Sci Med       Date:  2009-10-31       Impact factor: 4.634

Review 6.  Reconceptualising the external validity of discrete choice experiments.

Authors:  Emily Lancsar; Joffre Swait
Journal:  Pharmacoeconomics       Date:  2014-10       Impact factor: 4.981

7.  Effects of a drug minimization guide on prescribing intentions in elderly persons with polypharmacy.

Authors:  Ian A Scott; Leonard C Gray; Jennifer H Martin; Charles A Mitchell
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

8.  Stubbing out hypothetical bias: improving tobacco market predictions by combining stated and revealed preference data.

Authors:  John Buckell; Stephane Hess
Journal:  J Health Econ       Date:  2019-04-02       Impact factor: 3.883

9.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 10.  Discrete choice experiments in health economics: a review of the literature.

Authors:  Michael D Clark; Domino Determann; Stavros Petrou; Domenico Moro; Esther W de Bekker-Grob
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.